Current Report Filing (8-k)

Date : 08/01/2019 @ 12:10PM
Source : Edgar (US Regulatory)
Stock : Clovis Oncology Inc (CLVS)
Quote : 11.72  -0.38 (-3.14%) @ 11:09PM
Clovis Oncology share price Chart
After Hours
Last Trade
Last $ 11.60 ▼ -0.12 (-1.02%)

Current Report Filing (8-k)

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 1, 2019

Clovis Oncology, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
         
Delaware
 
001-35347
 
90-0475355
 
 
 
 
 
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
 
 
 
 
5500 Flatiron Parkway, Suite 100
Boulder, Colorado
 
 
 
 
80301
 
 
 
 
 
(Address of principal
executive offices)
 
 
 
(Zip Code)
Registrant’s telephone number, including area code: (303) 625-5000

Not Applicable
(Former name or former address, if changed since last report)
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  
 
Securities registered pursuant to Section 12(b) of the Act:
         
Title of each class
 
Trading symbol(s)
 
Name of each exchange on which registered
Common Stock par Value $0.001 per Share
 
CLVS
 
The NASDAQ Global Select Market


 
   
Item 2.02
 
Results of Operations and Financial Condition
 
     On August 1, 2019, Clovis Oncology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2019.  A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
 
     The information in this Item 2.02 of Form 8-K and the information incorporated by reference herein, including Exhibit 99.1 attached hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
 
     
Item 9.01
 
Financial Statements and Exhibits.
 
(d) Exhibits .
 
Number and Description
     
99.1
 
Press Release, dated August 1, 2019.


 
SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
 
 
   
 
CLOVIS ONCOLOGY, INC.
 
 
 
August 1, 2019
 
 
By:  
 /s/ Paul Gross   
 
 
 
 
Name:  
Paul Gross 
 
 
 
 
 
Title:  
Executive Vice President, General Counsel and Chief
Compliance Officer
 
 


EXHIBIT INDEX

 
Exhibit Number
 
Description
     
 


Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Clovis Oncology Charts.

Clovis Oncology (NASDAQ:CLVS)
Intraday Stock Chart

Today : Wednesday 11 December 2019

Click Here for more Clovis Oncology Charts.

Latest CLVS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191211 23:25:27